Y-mAbs Therapeutics Inc (YMAB US)

Analysis

Health Care • United States

Y-mAbs Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel antibody therapeutics and medicines for the treatment of cancer patients of all ages. Y-mAbs Therapeutics serves customers in the United States and Denmark.

Refresh

Focused

No publications yet

There aren’t any syndicated reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00